MiNK Therapeutics, Inc.
INKTNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $50.54M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $8.48$16.93
- Volume (live)
- -
- Avg. volume (3M)
- 19.23K
MiNK Therapeutics (INKT) Stock Price & Financial Analysis
MiNK Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.06 - $10.65 |
|---|---|
| 52-Week High | $16.93 |
| 52-Week Low | $8.48 |
| Open | $10.65 |
| Volume (last close) | 9.82K |
| Average Volume (3M) | 19.23K |
| 50-Day MA | $11.48 |
|---|---|
| 200-Day MA | $11.35 |
| 1-Year Change | −28.95% |
| Market Cap | 50.54M |
|---|---|
| Shares Outstanding | 5.02M |
| Price to Book (P/B) | -3.60 |
| EV/EBITDA | -3.38 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
MiNK Therapeutics at a Glance
As of the Oct 22, 2026 close, MiNK Therapeutics (INKT) has a market capitalization of $50.54M.
As of its latest reported balance sheet, it holds $8.81M in cash and securities against $0.00 of debt, a net cash position of $8.81M.
MiNK Therapeutics does not currently pay a dividend.
The share price is down 29.0% over the past year. At $10.06 (the Oct 22, 2026 close) it sits within its 52-week range of $8.48 to $16.93, below its 200-day moving average of $11.35.
Frequently Asked Questions About MiNK Therapeutics
What is the current stock price for INKT?
As of the Oct 22, 2026 close, INKT stock trades at $10.06. The 52-week range is $8.48–$16.93, with a day range of $10.06–$10.65.
What is the P/E ratio for INKT?
The P/E ratio (Price-to-Earnings) for INKT is shown in the Key Statistics section. This valuation metric helps compare MiNK Therapeutics, Inc. to industry peers.
Does INKT pay dividends?
MiNK Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for INKT?
Analyst ratings and recommendations for INKT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of INKT?
As of the Oct 22, 2026 close, MiNK Therapeutics's market capitalization is $50.5M, classifying it as a micro-cap company. MiNK Therapeutics operates in the Healthcare sector within the Biotechnology industry.